1. Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer
    Po-Shuan Huang et al, 2020, Cells CrossRef

  2. Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2


    Bohan Zhang et al, 2020, OTT CrossRef
  3. MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis
    Zhenqiang Sun et al, 2020, J Exp Clin Cancer Res CrossRef
  4. Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
    Tomasz M. Grzywa et al, 2020, Cancers CrossRef
  5. A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angiogenesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer
    Feifan Wang et al, 2021, J Exp Clin Cancer Res CrossRef
  6. MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
    Na-Hyun Lee et al, 2021, Biomedicines CrossRef
  7. Comprehensive analyses of competing endogenous RNA networks reveal potential biomarkers for predicting hepatocellular carcinoma recurrence
    Ping Yan et al, 2021, BMC Cancer CrossRef
  8. Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer
    Po-Shuan Huang et al, 2021, Cancers CrossRef
  9. Conservation of Epithelial-to-Mesenchymal Transition Process in Neural Crest Cells and Metastatic Cancer
    April Zhang et al, 2021, Cells Tissues Organs CrossRef
  10. Role of Hippo signaling pathway in occurrence, development, and treatment of primary hepatocellular carcinoma
    Hui-Xian Tang et al, 2022, WCJD CrossRef
  11. Association between the Expression Levels of MicroRNA-101, -103, and -29a with Autotaxin and Lysophosphatidic Acid Receptor 2 Expression in Gastric Cancer Patients
    Sara Tutunchi et al, 2022, Journal of Oncology CrossRef
  12. RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma
    Lu Zhang et al, 2022, JHC CrossRef
  13. Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma
    Haihong Hu et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
  14. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
    Geofrey Mahiki Mranda et al, 2022, Front. Oncol. CrossRef
  15. Identifying LATS2 as a prognostic biomarker relevant to immune infiltrates in human esophageal squamous cell carcinoma
    Minqi Zhu et al, 2022, Front. Genet. CrossRef
  16. The deadly cross-talk between Hippo pathway and epithelial–mesenchymal transition (EMT) in cancer
    Ioanna Akrida et al, 2022, Mol Biol Rep CrossRef
  17. YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).
    Jason W Lui et al, 2022, Pigment Cell Melanoma Res CrossRef
  18. The circSNX14 functions as a tumor suppressor via the miR-562/ LATS2 pathway in hepatocellular carcinoma cells
    Yan Wu et al, 2023, J Mol Histol CrossRef